Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Carboxytherapy may help increase hair growth in alopecia patients but requires ongoing treatment.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Corticosteroids worked better than anthralin cream for hair regrowth.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

The mixed preparation helped hair regrowth but wasn't better than minoxidil.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

2-deoxy D-glucose does not help with hair regrowth in alopecia areata.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

The hot-wire hair removal device is no better than shaving.

People with alopecia areata often have lower vitamin D levels than healthy people.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Photobiomodulation improves the quality of life for people with hair loss.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Using a laser with bimatoprost solution works better for hair regrowth in alopecia areata than bimatoprost alone.

Combining calcipotriol and PRP is most effective for treating Alopecia Areata.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Tofacitinib may effectively regrow hair in alopecia totalis patients.